PAA
AGN

Peregrine Asset Advisers’s Allergan Inc AGN Stock Holding History

Peregrine Asset Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,126
Closed -$302K – 131
2016
Q1 		$302K Sell
1,126
-500
-31% -$134K 0.23% 77
2015
Q4 		$508K Sell
1,626
-9,593
-86% -$3M 0.44% 46
2015
Q3 		$3.05M Buy
11,219
+750
+7% +$204K 3.11% 13
2015
Q2 		$3.18M Buy
+10,469
New +$3.18M 2.38% 14
2014
Q2 		– Sell
-3,600
Closed -$4.47M – 152
2014
Q1 		$4.47M Buy
3,600
+600
+20% +$73.1K 3.45% 5
2013
Q4 		$333K Hold
3,000
– – 0.29% 76
2013
Q3 		$271K Sell
3,000
-200
-6% -$18K 0.26% 101
2013
Q2 		$270K Buy
+3,200
New +$332K 0.28% 95

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
MCM
Mengis Capital Management Portland, Oregon $658M AUM 39.64% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $815M AUM 30.42% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
SIA
Starfire Investment Advisers Southfield, Michigan $209M AUM 2.6% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return

Peregrine Asset Advisers's AGN Position: Q2 2016 in Review

Peregrine Asset Advisers sold out of Allergan Inc (AGN) in Q2 2016, closing a stake of 1,126 shares — an estimated $302K sold.

Peregrine Asset Advisers first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $4.47M in Q1 2014. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Peregrine Asset Advisers reported no remaining Allergan Inc position as of Q2 2016 after selling out during the quarter.
  • Peregrine Asset Advisers sold 1,126 Allergan Inc shares in Q2 2016, an estimated $302K.
  • Peregrine Asset Advisers first reported a position in Allergan Inc in Q2 2013 and held it in 8 quarters.
  • Peregrine Asset Advisers's Allergan Inc position peaked at $4.47M in Q1 2014.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2016.

Based on Peregrine Asset Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.